Oculis Eyes Success In Wide Range Of Ophthalmic Conditions
Swiss Firm Attracting Attention
Oculis has enjoyed a strong first six months of 2023 after demonstrating the potential of OCS-01 to treat a variety of eye conditions and establishing a presence in the US.
